Total trials
157
Active
34
Phase 3
6
Total enrollment
78,410
Pipeline matrix
Showing 15 of 15 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Nebivolol | — | — | — | — | — | 1 | |
| Ivabradine | — | — | — | — | — | 1 | |
| FLOT + HIPEC + Surgery | — | — | — | — | — | 1 | |
| FLOT + Surgery | — | — | — | — | — | 1 | |
| noradrenaline infusion for management blood pressure | — | — | — | — | — | 1 | |
| standard blood pressure management | — | — | — | — | — | 1 | |
| Chemoimmunotherapy | — | — | — | — | — | 1 | |
| Celiac Plexus Block | — | — | — | — | — | 1 | |
| ESP block | — | — | — | — | — | 1 | |
| Lidacaine | — | — | — | — | — | 1 | |
| Advanced Platelet-Rich Fibrin | — | — | — | — | — | 1 | |
| Autogenous Demineralized Dentin Matrix | — | — | — | — | — | 1 | |
| Remifentanil-based general anesthesia | — | — | — | — | — | 1 | |
| Opioid-free general anesthesia | — | — | — | — | — | 1 | |
| Balanced anesthesia with opioids | — | — | — | — | — | 1 |
Next readouts
- 2025-04-30
- 2026-01
- 2026-09-30
- 2026-12-01
- 2026-12-31
- 2026-12-31
- 2027-06-30
- 2027-12-31
- 2029-01-01
Top conditions
- Gastric Cancer5
- Endometriosis4
- Infertility Unexplained4
- Rectal Cancer4
- Hypertension3
- Colorectal Cancer3
- Neuroendocrine Tumors3
- Amyotrophic Lateral Sclerosis3
Frequently asked questions about Jagiellonian University
- How many clinical trials does Jagiellonian University have on ClinicalTrials.gov?
- Jagiellonian University is listed as the lead sponsor on 157 clinical trials in ClinicalTrials.gov, 34 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Jagiellonian University's trials are in Phase 3?
- 6 of Jagiellonian University's trials are in Phase 3, spread across 15 active drug programs.
- What therapeutic areas does Jagiellonian University focus on?
- Jagiellonian University's most-studied conditions on ClinicalTrials.gov are Gastric Cancer, Endometriosis, Infertility Unexplained, Rectal Cancer, Hypertension.
- When are Jagiellonian University's next clinical trial readouts?
- Jagiellonian University has 9 upcoming primary-completion readouts tracked here; the soonest is “Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)”, expected around 2025-04-30.